ATE534741T1 - Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung - Google Patents

Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung

Info

Publication number
ATE534741T1
ATE534741T1 AT04805294T AT04805294T ATE534741T1 AT E534741 T1 ATE534741 T1 AT E534741T1 AT 04805294 T AT04805294 T AT 04805294T AT 04805294 T AT04805294 T AT 04805294T AT E534741 T1 ATE534741 T1 AT E534741T1
Authority
AT
Austria
Prior art keywords
strain
leishmania infantum
reduced virulence
protozoan
protozoan strain
Prior art date
Application number
AT04805294T
Other languages
English (en)
Inventor
Da Silva Anabela Cordeira
Ali Ouaissi
Denis Sereno
Jean-Baptiste Vergnes
Original Assignee
Inst Rech Developpement Ird
Univ Do Porto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Developpement Ird, Univ Do Porto filed Critical Inst Rech Developpement Ird
Application granted granted Critical
Publication of ATE534741T1 publication Critical patent/ATE534741T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04805294T 2003-10-29 2004-10-25 Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung ATE534741T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312689A FR2861740B1 (fr) 2003-10-29 2003-10-29 Souches de protozoaire de virulence attenuee et leur utilisation
PCT/FR2004/002735 WO2005044844A2 (fr) 2003-10-29 2004-10-25 Souches de protozoaire de virulence attenuee et leur utilisation

Publications (1)

Publication Number Publication Date
ATE534741T1 true ATE534741T1 (de) 2011-12-15

Family

ID=34429739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805294T ATE534741T1 (de) 2003-10-29 2004-10-25 Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung

Country Status (8)

Country Link
US (1) US7732188B2 (de)
EP (1) EP1678305B1 (de)
AT (1) ATE534741T1 (de)
AU (1) AU2004286879B2 (de)
CA (1) CA2543866A1 (de)
ES (1) ES2393610T3 (de)
FR (1) FR2861740B1 (de)
WO (1) WO2005044844A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2008002778A2 (en) 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
WO2008033711A2 (en) 2006-09-14 2008-03-20 Boston Scientific Limited Medical devices with drug-eluting coating
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
EP2187988B1 (de) 2007-07-19 2013-08-21 Boston Scientific Limited Endoprothese mit nicht verschmutzender oberfläche
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
WO2009018340A2 (en) 2007-07-31 2009-02-05 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (ja) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド 広い表面積を有する医療器具用のコーティング
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
FR2924611B1 (fr) * 2007-12-07 2012-10-12 Isabelle Delbosc Nouvelle souche homeopathique comprenant un nosode de protozoaire du genre trypanosoma
WO2009131911A2 (en) 2008-04-22 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US20200215185A1 (en) * 2019-01-09 2020-07-09 Emv Enhance (Hk) Limited Compositions and methods for enhancing immune response to vaccination and improving vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE236252T1 (de) 1993-09-03 2003-04-15 Univ Mcgill Differentiell exprimierte leishmania gene und proteinen
US5965143A (en) * 1996-03-12 1999-10-12 Fasel; Nicolas Joseph Immunity to trypanosomatids species
US6162638A (en) 1996-05-06 2000-12-19 Universite Laval Attenuated strains of leishmania and uses thereof
GB9706930D0 (en) 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
WO2005044844A3 (fr) 2005-07-07
AU2004286879A1 (en) 2005-05-19
AU2004286879B2 (en) 2010-07-22
ES2393610T3 (es) 2012-12-26
CA2543866A1 (fr) 2005-05-19
US20070224224A1 (en) 2007-09-27
FR2861740A1 (fr) 2005-05-06
US7732188B2 (en) 2010-06-08
FR2861740B1 (fr) 2005-12-16
EP1678305B1 (de) 2011-11-23
WO2005044844A2 (fr) 2005-05-19
EP1678305A2 (de) 2006-07-12

Similar Documents

Publication Publication Date Title
ATE534741T1 (de) Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung
NO20080074L (no) Modifiserte mikroorganismer med inaktivert lactat-dehydrogenasegen
ATE449840T1 (de) Alpha-amylasevariante mit veränderten eigenschaften
ATE543907T1 (de) Stresstolerante baumwollpflanzen
PL1730315T3 (pl) Polimorfizmy w genie NOD2/CARD15
SG142154A1 (en) Methods for genomic analysis
CY1115745T1 (el) Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου
BRPI0409362A (pt) combinação simbiótica
BR112015012789A2 (pt) composição que compreende um agente de controle biológico e um inseticida
IS8254A (is) örugg stökkbreytt veirubóluefni
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
ES2309765T3 (es) Tetrahidropiridotiofenos.
BR0214787A (pt) Compósitos elastoméricos, combinações de elastÈmeros e métodos
ATE507721T2 (de) Milbenzusammensetzung
DK1842920T3 (da) Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein
DE602005007220D1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
HUP0400393A2 (hu) Eljárás vírusszaporításra
DE60317693D1 (de) Methode und verwendung von thermostabilen rna-ligasen
DE60228089D1 (de) Nukleinsäureamplifikation mit duplexzwischenprodukten
EP1784489A4 (de) Lineares dna-fragment für markierungslose deletion, neuer stamm mit gehemmter biofilmbildung und herstellungsverfahren dafür
HUP0500383A2 (hu) Mikroorganizmusok és eljárások pantotenát fokozott termelésére
ATE549026T1 (de) Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren
DE602005016697D1 (de) Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen
ATE533779T1 (de) Isoliertes photoprotein mtclytin, sowie dessen verwendung
WO2002080755A3 (en) Kits and methods for assessing oxidative stress